MEDBOX | Toolbox Covaxin

Covaxin

TOOLBOX

Advanced search

Create your MEDBOX

Covaxin

TOOLBOX

Advanced search

Create your MEDBOX

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

6 records

	Recomendaciones provisionales para el uso de la vacuna BBV152 COVAXIN® de Bharat Biotech contra la COVID-19: orientaciones provisionales, primera publicación: 3 de noviembre de 2021, actualización: 15 Organización Mundial de la Salud OMS (2022) C_WHO View PDF(3) Download (3) Add to my MEDBOX Tags: COVID-19, Vaccination, Covaxin, Source: https://apps.who.int/iris/bitstream/hand
	Suspension of supply of COVID-19 vaccine (COVAXIN®) World Health Organization WHO (2022) C_WHO Open external link (69) Add to my MEDBOX 2 April 2022 Tags: Covaxin, Vaccines, COVID-19, suspension, Source: https://www.who.int/news/item/02-04-2022
	Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19 World Health Organization WHO (2022) C_WHO View PDF(34) Download (38) Add to my MEDBOX These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. This document has been updated: version 15 March 2022. The vaccine is formulated from an inactivated SARS-CoV-2 antigen and is presented in single dose vials and multidose vials of 5, 10 and 20 doses Tags: inactivated vaccines, COVID-19, India, Source: https://apps.who.int/iris/rest/bitstream
	COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine World Health Organization WHO (2022) C_WHO View PDF(16) Download (12) Add to my MEDBOX The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements. Tags: inactivated vaccines, COVID-19, Covaxin, Source: https://www.who.int/docs/default-source/
	Covaxin Bharat Biotech (2021) CC Open external link (237) Add to my MEDBOX COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility. The vaccine received DCGI approval for Phase I & II Human Clinical Trials and the trials commenced across India from July, 2020. After successful completion of the interim analysis from the Phase 1 & 2 clinical trials of COVAXINTM, Bharat Biotech received DCGI approval for Phase 3 clinical trials in 26,000 participants in over 25 centres across India Tags: India, vaccine, vaccine trial, vaccine candidates, SARS-CoV-2, COVID-19, Source: https://www.bharatbiotech.com/covaxin.ht
	Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca BBC (2020) CC Open external link (264) Add to my MEDBOX Tags: Vaccination, approval, COVID-19, India, vaccine candidates, vaccine trial, Source: https://www.bbc.com/news/world-asia-indi

6 records

6 records